Skip to main content
. 2022 Jun 16;13:911105. doi: 10.3389/fphar.2022.911105

FIGURE 6.

FIGURE 6

CGRP antagonist reverts the anxiety-like symptoms and increased exploratory activity after unpredictable sound stress. BIBN4096BS (olcegepant, 100 mg/kg) intraperitoneal (i.p.) administration reverted the alterations of different behavioral parameters: Time spent (A) grooming (B) sniffing (C) rearing (D) the number of crossings (E) representative image of crossings represented by track plot (F) time in the peripheral zone were observed in the open field test at day 7 post-stress (ST group) or in non-stressed group (NST) 1 hour-post BIBN4096BS administration. (G) Representative image of time in the peripheral zone represented by heat map. Data are expressed as mean ± S.E.M. (n = 8). *p < 0.05, when compared between the sexes within the ST group. # p < 0.05 when compared to the NST group. § p < 0.05 when compared to the vehicle (Veh) treated group [repeated measures two-way ANOVA followed by Bonferroni’s post hoc test].